Dr. Pfanzelter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2650 Ridge Ave
Evanston, IL 60201Phone+1 847-570-2112
Summary
- Nicklas Pfanzelter, MD, is an Oncologist based in Evanston, IL, specializing in Genitourinary Oncology. A graduate of the University of Chicago Division of the Biological Sciences The Pritzker School of Medicine, Dr. Pfanzelter completed his internship, residency, and fellowship at the University of Pennsylvania Health System. He is currently employed at Endeavor Health and has previous experience as an Assistant Professor at Rush. His professional experience includes bladder, prostate, kidney and testicular cancer.
Education & Training
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2013- University of Pennsylvania Health SystemResidency, Internal Medicine, 2007 - 2010
- University of Pennsylvania Health SystemInternship, Internal Medicine, 2007 - 2008
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2007
Certifications & Licensure
IL State Medical License 2013 - 2026
PA State Medical License 2007 - 2014- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- 3 citationsThe Efficacy of Lenvatinib and Everolimus in Chromophobe-type Non-Clear-Cell Renal Cell Carcinoma: A Case Report and Literature Review.Candice Schwartz, Nicklas R Pfanzelter, Timothy M. Kuzel
Clinical Genitourinary Cancer. 2017-05-25 - 1 citationsExpert Consensus Recommendations on the Management of Treatment-emergent Adverse Events Among Men with Prostate Cancer Taking Poly-ADP Ribose Polymerase Inhibitor + No...Neal D Shore, Michael S Broder, Pedro C Barata, Tony Crispino, André P Fay
European Urology Oncology. 2024-06-11 - 27 citationsEvaluating the safety and efficacy of axitinib in the treatment of advanced renal cell carcinoma.Orvar Gunnarsson, Nicklas R Pfanzelter, Roger B. Cohen, Stephen M. Keefe
Cancer Management and Research. 2015-02-11
Press Mentions
Carevive Launches Clinical Oncology Program in Collaboration with NorthShore University HealthSystem to Improve Cancer TreatmentNovember 9th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
